Valley National Advisers’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20
| Closed | -$1K | – | 1084 |
|
|
2023
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 882 |
|
|
2023
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 920 |
|
|
2022
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 892 |
|
|
2022
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 939 |
|
|
2022
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 921 |
|
|
2022
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 935 |
|
|
2021
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 932 |
|
|
2021
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 894 |
|
|
2021
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 907 |
|
|
2021
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 867 |
|
|
2020
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 822 |
|
|
2020
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 793 |
|
|
2020
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 795 |
|
|
2020
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 780 |
|
|
2019
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 771 |
|
|
2019
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 779 |
|
|
2019
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 748 |
|
|
2019
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 770 |
|
|
2018
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 788 |
|
|
2018
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 707 |
|
|
2018
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 682 |
|
|
2018
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 665 |
|
|
2017
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 691 |
|
|
2017
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 675 |
|
|
2017
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 621 |
|
|
2017
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 628 |
|
|
2016
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 674 |
|
|
2016
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 669 |
|
|
2016
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 629 |
|
|
2016
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 617 |
|
|
2015
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 618 |
|
|
2015
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 626 |
|
|
2015
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 627 |
|
|
2015
Q1 | $0 | Buy |
+20
| New | +$176 | ﹤0.01% | 587 |
|
Other funds holding FOLD
PA
ACA
RG
PAI
Valley National Advisers's FOLD Position: Q3 2023 in Review
Valley National Advisers sold out of Amicus Therapeutics (FOLD) in Q3 2023, closing a stake of 20 shares — an estimated $1K sold.
Valley National Advisers first reported a position in FOLD in Q1 2015 and held it in 34 quarters. The position peaked at $1K in Q2 2023. 228 funds tracked by Wall St. Rank hold FOLD as of Q3 2023.
- Valley National Advisers reported no remaining Amicus Therapeutics position as of Q3 2023 after selling out during the quarter.
- Valley National Advisers sold 20 Amicus Therapeutics shares in Q3 2023, an estimated $1K.
- Valley National Advisers first reported a position in Amicus Therapeutics in Q1 2015 and held it in 34 quarters.
- Valley National Advisers's Amicus Therapeutics position peaked at $1K in Q2 2023.
- 228 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2023.
Based on Valley National Advisers's 13F filing for Q3 2023, filed 13 Nov 2023.